Osteonecrosis in Children and Adolescents With... (2019 study) Skip to main content
Clinical Study Anticancer research 2019

Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia: Early Diagnosis and New Treatment Strategies.

Biddeci G, Bosco G, Varotto E, Corradin M, Geranio G, Tridello G, et al., Anticancer research, 2019

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed 495 children and young adolescents treated for acute lymphoblastic leukemia between 2000 and 2017 to see how often bone damage called osteonecrosis occurred, what was linked to it, and how patients did afterward.

What They Found

This clinical study of 495 young patients with acute lymphoblastic leukemia found that 23 (4.6 percent) developed osteonecrosis, and that it was linked to older age and a higher steroid dose. Older age had a p-value of less than 0.0001 and higher steroid dose had a p-value of 0.0013. All 23 patients received standard therapies, and hyperbaric oxygen therapy was also performed in 8 of them. At follow-up, 15 patients were stable: 6 had no symptoms, 5 had pain during activity, and 4 had mild limits on function. The abstract does not say how the other 8 patients did, and it does not compare the 8 who received hyperbaric oxygen with those who did not.

What This Means for Canadian Patients

The authors say screening MRI in patients without symptoms could allow earlier diagnosis of osteonecrosis, so that conservative treatment can start sooner. They state that hyperbaric oxygen therapy "could have beneficial effects" in these patients. That is a cautious statement, and the abstract gives no results showing that the therapy caused any improvement. It does not report the pressure or the number of sessions used.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

Only 8 of the 23 patients received hyperbaric oxygen therapy, and the abstract reports no comparison group and no outcome data for those 8 alone, so it cannot show whether the therapy changed their results.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Aging & Longevity
Source Pubmed
PubMed ID 30842156
Year Published 2019
Journal Anticancer research
MeSH Terms Adolescent; Adult; Bone and Bones; Child; Child, Preschool; Early Diagnosis; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Young Adult

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology